Evidence-based ophthalmology

Richard Wormald; Kay Dickersin

doi:10.1016/j.ophtha.2013.08.032

Evidence-based ophthalmology

Richard Wormald, Kay Dickersin

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	2361-2363.e1
Journal	Ophthalmology
Volume	120
Issue number	12
DOIs	https://doi.org/10.1016/j.ophtha.2013.08.032
State	Published - Dec 2013
Externally published	Yes

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/j.ophtha.2013.08.032

Cite this

@article{ac2e8cc3701b45bb995a45b8f5efa0c8,

title = "Evidence-based ophthalmology",

author = "Richard Wormald and Kay Dickersin",

note = "Funding Information: Financial Disclosure(s): Richard Wormald is funded by financial support from the Department of Health (UK) through the award made by the National Institute for Health Research to Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. Funding Information: Discussions began immediately between Kay Dickersin and Iain Chalmers about the need for an Eyes and Vision Group (CEVG) within the collaboration, and the seed was sown for the group when later that year Iain Chalmers and Richard Wormald met at the Oxford Ophthalmological Congress. Two years later, an exploratory meeting was held in Montpelier (France) with eye care professionals largely from Europe and including Kay Dickersin, one of the cofounders of the Collaboration and Director of the US Cochrane Centre. Another key supporter and Collaboration cofounder was Alessandro Liberati, who with Luca Rossetti was an author of the first and highly influential systematic review in the ophthalmic literature on medical interventions for glaucoma 4 —a much-needed alarm to the specialty to get to establish appropriate evidence in support of practice standards. The CEVG was officially registered in 1997 with its editorial base at the Institute of Ophthalmology in London with funding from the National Institute for Health Research (the UK's equivalent to the US National Institutes of Health). And in 2002, the National Eye Institute, part of the National Institutes of Health, funded a CEVG Satellite, currently based at The Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland (CEVG@US). Copyright: Copyright 2018 Elsevier B.V., All rights reserved.",

year = "2013",

month = dec,

doi = "10.1016/j.ophtha.2013.08.032",

language = "English (US)",

volume = "120",

pages = "2361--2363.e1",

journal = "Ophthalmology",

issn = "0161-6420",

publisher = "Elsevier Inc.",

number = "12",

}

TY - JOUR

T1 - Evidence-based ophthalmology

AU - Wormald, Richard

AU - Dickersin, Kay

N1 - Funding Information: Financial Disclosure(s): Richard Wormald is funded by financial support from the Department of Health (UK) through the award made by the National Institute for Health Research to Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. Funding Information: Discussions began immediately between Kay Dickersin and Iain Chalmers about the need for an Eyes and Vision Group (CEVG) within the collaboration, and the seed was sown for the group when later that year Iain Chalmers and Richard Wormald met at the Oxford Ophthalmological Congress. Two years later, an exploratory meeting was held in Montpelier (France) with eye care professionals largely from Europe and including Kay Dickersin, one of the cofounders of the Collaboration and Director of the US Cochrane Centre. Another key supporter and Collaboration cofounder was Alessandro Liberati, who with Luca Rossetti was an author of the first and highly influential systematic review in the ophthalmic literature on medical interventions for glaucoma 4 —a much-needed alarm to the specialty to get to establish appropriate evidence in support of practice standards. The CEVG was officially registered in 1997 with its editorial base at the Institute of Ophthalmology in London with funding from the National Institute for Health Research (the UK's equivalent to the US National Institutes of Health). And in 2002, the National Eye Institute, part of the National Institutes of Health, funded a CEVG Satellite, currently based at The Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland (CEVG@US). Copyright: Copyright 2018 Elsevier B.V., All rights reserved.

PY - 2013/12

Y1 - 2013/12

UR - http://www.scopus.com/inward/record.url?scp=84887924594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887924594&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2013.08.032

DO - 10.1016/j.ophtha.2013.08.032

M3 - Editorial

C2 - 24246821

AN - SCOPUS:84887924594

SN - 0161-6420

VL - 120

SP - 2361-2363.e1

JO - Ophthalmology

JF - Ophthalmology

IS - 12

ER -

Evidence-based ophthalmology

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this